Enviaments recents

ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective

Koessler, Thibaud; Alsina Maqueda, Maria; Arnold, Dirk; Ben-Aharon, Irit; Collienne, M.; Lutz, Manfred (Data de publicació: 2022-10-28)

Neuroendocrine tumours; Pancreatic cancer; Stomach cancer

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy

Czajka-Francuz, Paulina; Prendes, Maria J.; Mankan, Arun K; Pabla, Sarabjot; Ramkissoon, Shakti; Quintana, Angela; Peiró, Sandra (Data de publicació: 2023-08-14)

Cancer; Immunosuppression mechanisms; Tumor microenvironment

High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density

Corvigno, Sara; Fernebro, Josefin; Severin Karlsson, Josefin; Martín-Bernabé, Alfonso; Martin de la Fuente, Laura; Mezheyeuski, Artur (Data de publicació: 2025-04-01)

Fibroblast; High-grade serous ovarian cancer; T cell

Spatial immunophenotyping of the tumour microenvironment in non–small cell lung cancer

Backman, Max; Strell, Carina; Lindberg, Amanda; Mattsson, Johanna; Elfving, Hedvig; Brunnström, Hans; Mezheyeuski, Artur (Data de publicació: 2023-05-22)

Checkpoint therapy; Lung cancer; Tumour microenvironment

Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer

Nag, Shona; ray coquard, isabelle; Gupta, Sudeep; Pathak, Anand; Lopez, Jose Rafael; Mulya Sari, Resti; OAKNIN, ANA (Data de publicació: 2025-08-12)

Pan-asian; Epithelial ovarian cancer; Treatment

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study

Vahdat, Linda T.; Forero-Torres, Andres; Blackwell, Kimberly; Telli, Melinda L.; Melisko, Michelle; Cortés Castan, Javier; Schmid, Peter (Data de publicació: 2022-02-22)

Breast cancer; Cancer

Dostarlimab: From preclinical investigation to drug approval and future directions

Cicala, Carlo Maria; Musacchio, lucia; Scambia, Giovanni; Lorusso, Domenica (Data de publicació: 2023-06-28)

Endometrial cancer; Immunotherapy; Rectal cancer

Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial

Fakih, Marwan; Prager, M.D., Gerald; Van Cutsem, Eric; Tabernero, Josep; taieb, julien; Ciardiello, Fortunato (Data de publicació: 2024-03-20)

KRAS mutation; Metastatic colorectal cancer; Overall survival

Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)

Doi, Toshihiko; Hosaka, Hisashi; Longo-Muñoz, Federico; Alsina Maqueda, Maria; Thuss-Patience, Peter; Santoro, Armando; Shitara, Kohei (Data de publicació: 2022-09-09)

Age groups; Gastrointestinal neoplasms; Trifluridine

Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management

Veillon, Remi; Sakai, Hiroshi; Cortot, Alexis; Le, Xiuning; Smit, Egbert; Felip Font, Enriqueta (Data de publicació: 2022-09-09)

Edema; Nausea; Non-small cell lung cancer

Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma

González-Martínez, Silvia; Pérez-Mies, Belén; Pizarro, David; Caniego-Casas, Tamara; Cortés Castan, Javier; Palacios, José (Data de publicació: 2022-01-31)

Transició epitelial-mesenquimal; Carcinoma de mama metaplàstic

Identification of Enhancer-Promoter Contacts in Embryoid Bodies by Quantitative Chromosome Conformation Capture (4C)

Tian, Tian V; Vidal, Enrique; Graf, Thomas; Stik, Grégoire (Data de publicació: 2021-10-29)

Cèl·lules mare embrionàries; Seqüenciació d'alt rendiment

Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis

O’Shaughnessy, Joyce; Cortés Castan, Javier; Twelves, Chris; Goldstein, Lori J.; Alexis, Karenza; Xie, Ran (Data de publicació: 2021-09-03)

Càncer de mama; Marcadors predictius; Pronòstic

Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer

Mansoor, Wasat; Joo, Seongjung; Norquist, Josephine M; Kato, Ken; Sun, Jong-Mu; Shah, Manish A.; Alsina, Maria (Data de publicació: 2024-10-08)

Chemotherapy; Esophageal cancer; Health-related quality of life

Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial

Paik, Paul K.; Garassino, Marina; Le, Xiuning; Sakai, Hiroshi; Veillon, Remi; MAZIERES, JULIEN; FELIP, ENRIQUETA (Data de publicació: 2023-10-02)

Tepotinib; Non-small cell lung cancer

External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry

Jimenez-Fonseca, Paula; Martinez-Torron, Alba; Alsina Maqueda, Maria; Custodio, Ana; Serra, Olbia; Carmona-Bayonas, Alberto (Data de publicació: 2022-02-22)

Quimioteràpia; Càncer gàstric; Trastuzumab

Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis

Swain, Sandra; Macharia, Harrison; Cortés Castan, Javier; Hurvitz, Sara; Gianni, Luca; Dang, Chau (Data de publicació: 2022-11-28)

Early breast cancer; Event-free survival; Pathologic complete response

Comparative Analysis of Ultrasonography and MicroCT Imaging for Organ Size Evaluation in Mice

Ferrer Clotas, Marina; Jiménez Catalán, Juan José; Cámara Serrano, Juan Antonio (Data de publicació: 2025-09-16)

Mice; Organ volume; Ultrasound

Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial

Arteaga, Carlos; Rojo, Federico; Gonzalez-Perez, Abel; Albanell, Joan; Gamez-Pozo, Angelo; Bellet Ezquerra, Meritxell (Data de publicació: 2025-08-12)

Biomarkers; Hormone receptor-positive; Advanced breast cancer

A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma

Palomba, M. Lia; Ghione, Paola; Patel, Anik R.; Nahas, Myrna; Beygi, Sara; Hatswell, Anthony; Bobillo Varela, Sabela (Data de publicació: 2023-03-06)

Follicular lymphoma; Axicabtagene ciloleucel; Comparative effectiveness

Articles científics - VHIO: Enviaments recents

ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective ﻿

Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy ﻿

High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density ﻿

Spatial immunophenotyping of the tumour microenvironment in non–small cell lung cancer ﻿

Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer ﻿

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study ﻿

Dostarlimab: From preclinical investigation to drug approval and future directions ﻿

Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial ﻿

Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS) ﻿

Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management ﻿

Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma ﻿

Identification of Enhancer-Promoter Contacts in Embryoid Bodies by Quantitative Chromosome Conformation Capture (4C) ﻿

Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis ﻿

Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer ﻿

Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial ﻿

External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry ﻿

Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis ﻿

Comparative Analysis of Ultrasonography and MicroCT Imaging for Organ Size Evaluation in Mice ﻿

Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial ﻿

A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma ﻿